Suven Life Sciences Ltd.

View in App
56.90 +0.15 ▲0.3%

26 May 2023, 04:14:28 PM
Volume: 52,732

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.suven.com
Market Cap 1,243.67 Cr.
Enterprise Value(EV) 1,059.39 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -5.42 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 31.87 Trailing Twelve Months Ending 2023-03
Book Value / Share 17.21 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.31 Calculated using Price: 57.01
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 21.81 Cr. 218,073,717 Shares
FaceValue 1
About Suven Life Sciences Ltd.
Suven Life Sciences was promoted by Mrs. and Mr. Venkat Jasti in 1989, as a Private Limited Company. Later it was converted into a Public Limited Company in January 1995.

Suven Life Sciences Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Suven Life Sciences Ltd. Performance

View details >>
1 Day
+0.26%
1 Week
1 Month
+1.25%
3 Month
-0.44%
6 Month
-11.71%
1 Year
-20.62%
2 Year
-35.09%
5 Year
-67.66%
10 Year
+153.68%

Suven Life Sciences Ltd. Fundamental Ratios

View details >>
9 years 2008-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 8.04 32.91 12.50 13.81 17.25 -4.75 -49.27 -67.29 -145.90
Return on Capital Employed (%) 7.51 37.93 15.43 18.19 26.01 0.40 -54.67 -60.09 -117.81
Return on Assets (%) 4.49 22.38 8.87 9.97 12.84 -3.31 -27.07 -28.99 -57.51

Suven Life Sciences Ltd. Balance Sheet

View details >>
Particulars 9 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 559 595 667 767 239 143 108 96 375
Non Curr. Liab. 86 41 28 30 25 12 5 4 2
Curr. Liab. 127 211 208 226 157 120 110 102 11
Minority Int.
Equity & Liab. 773 846 903 1,023 421 275 222 202 389
Non Curr. Assets 291 319 322 350 22 116 26 41 137
Curr. Assets 477 528 581 674 398 160 197 160 252
Misc. Exp. not W/O 5
Total Assets 773 846 903 1,023 421 275 222 202 389

Suven Life Sciences Ltd. Profit and Loss

View details >>
Particulars 10 years 2008-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 117 521 500 544 625 286 14 13 12 14
Other Income 3 9 20 21 23 27 14 8 5 8
Total Income 120 529 519 565 649 313 28 21 17 22
Total Expenditure -105 -361 -398 -414 -424 -297 -130 -93 -134 -139
PBIDT 16 168 121 150 225 16 -102 -72 -117 -117
Interest -5 -5 -6 -6 -5 -2 -1 -1 -1 0
Depreciation -4 -12 -18 -21 -25 -14 -4 -4 -4 -7
Taxation 2 -43 -26 -36 -72 -24 12 5
Exceptional Items 6
PAT 8 109 72 87 124 -24 -94 -72 -122 -118
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 8 109 72 87 124 -24 -94 -72 -122 -118
Adjusted EPS 1 8 5 6 9 -2 -7 -5 -8 -6

Suven Life Sciences Ltd. Cash Flow

View details >>
Particulars 8 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 143 68 109 70 -53 -135 -96 -128
Cash Fr. Inv. -110 -39 -311 -1 37 146 56 -22
Cash Fr. Finan. 179 -68 -30 -52 5 3 35 146
Net Change 212 -39 -232 17 -11 14 -5 -4
Cash & Cash Eqvt 279 241 9 26 0 15 9 5

Suven Life Sciences Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 60.00 60.00 60.00 60.00 64.98 64.98 64.98 69.57 69.57
Public 40.00 40.00 40.00 40.00 35.02 35.02 35.02 30.43 30.43
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Suven Life Sciences Ltd. Announcements

View details >>
Thu, 25 May 2023
Annual Secretarial Compliance Report
Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2023
Wed, 24 May 2023
Annual Secretarial Compliance Report
Submission of Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2023
Fri, 19 May 2023
Disclosure under SEBI Takeover Regulations
Venkateswarlu Jasti has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Suven Life Sciences Ltd. Technical Scans

View details >>
Fri, 26 May 2023
20 SMA Crossing 100 SMA From Below 20 SMA Crossing 100 SMA From Below
RSI Trending Up RSI Trending Up
Thu, 25 May 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
RSI Trending Down RSI Trending Down
William %R Crossed -80 From Above William %R Crossed -80 From Above

Suven Life Sciences Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 232,891.45 969.90 +2.6%
Divi's Laboratories Ltd. 93,212.66 3,514.00 +2.3%
Cipla Ltd. 76,767.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. 75,437.96 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. 66,286.16 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. 57,611.88 1,700.25 -0.1%
Mankind Pharma Ltd. 53,007.87 1,323.60 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.48 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 51.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 27.40 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 16.74 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 86.68 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 69.29 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 39.70 1,323.60 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.16 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,514.00 +2.3%
Cipla Ltd. Consolidated 2023-03 3.28 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.24 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.75 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 9.03 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.10 1,323.60 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,323.60 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,323.60 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 969.90 +2.6%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,514.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 951.35 +0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,530.05 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,609.90 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,700.25 -0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,323.60 -0.3%

Suven Life Sciences Ltd. FAQ's

What is Suven Life Sciences share price?
Can I buy Suven Life Sciences shares now?
What is the Market Cap of Suven Life Sciences?
What are the key metrics to analyse Suven Life Sciences?
What is the 52 Week High and Low of Suven Life Sciences?
What is the trend of Suven Life Sciences share price?